Neville Rodie & Shaw Inc Merck & Co., Inc. Transaction History

Neville Rodie & Shaw Inc

  • $1.32 Billion
  • Q2 2024

A detailed history of Neville Rodie & Shaw Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 183,043 shares of MRK stock, worth $20.8 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares
183,043
Previous 184,768 0.93%
Holding current value
$20.8 Million
Previous $24.4 Million 7.05%
% of portfolio
1.72%
Previous 1.86%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 01, 2024
SELL
$123.8 - $132.96 $213,555 - $229,356
-1,725 Reduced 0.93%
183,043 $22.7 Million
Q1 2024

Apr 09, 2024
SELL
$113.24 - $131.95 $95,687 - $111,497
-845 Reduced 0.46%
184,768 $24.4 Million
Q4 2023

Jan 02, 2024
SELL
$100.18 - $109.02 $235,923 - $256,742
-2,355 Reduced 1.25%
185,613 $20.2 Million
Q3 2023

Oct 10, 2023
SELL
$102.95 - $114.33 $39,121 - $43,445
-380 Reduced 0.2%
187,968 $19.4 Million
Q2 2023

Jul 06, 2023
SELL
$108.61 - $118.38 $500,800 - $545,850
-4,611 Reduced 2.39%
188,348 $21.7 Million
Q1 2023

Apr 04, 2023
SELL
$102.94 - $114.86 $61,764 - $68,916
-600 Reduced 0.31%
192,959 $20.5 Million
Q4 2022

Jan 03, 2023
BUY
$87.44 - $112.11 $288,552 - $369,963
3,300 Added 1.73%
193,559 $21.5 Million
Q3 2022

Oct 04, 2022
SELL
$84.53 - $94.96 $335,076 - $376,421
-3,964 Reduced 2.04%
190,259 $16.4 Million
Q2 2022

Jul 06, 2022
SELL
$83.49 - $94.64 $470,132 - $532,917
-5,631 Reduced 2.82%
194,223 $17.7 Million
Q1 2022

Apr 05, 2022
SELL
$73.51 - $82.4 $116,880 - $131,016
-1,590 Reduced 0.79%
199,854 $16.7 Million
Q4 2021

Jan 05, 2022
SELL
$72.28 - $90.54 $86,374 - $108,195
-1,195 Reduced 0.59%
201,444 $15.4 Million
Q3 2021

Oct 06, 2021
SELL
$71.68 - $78.83 $1.9 Million - $2.08 Million
-26,440 Reduced 11.54%
202,639 $15.2 Million
Q2 2021

Jul 06, 2021
SELL
$70.31 - $77.77 $788,175 - $871,801
-11,210 Reduced 4.67%
229,079 $17.8 Million
Q1 2021

Apr 08, 2021
SELL
$68.86 - $81.11 $162,509 - $191,419
-2,360 Reduced 0.97%
240,289 $18.5 Million
Q4 2020

Mar 04, 2021
SELL
$71.77 - $79.65 $765,498 - $849,546
-10,666 Reduced 4.21%
242,649 $19.8 Million
Q3 2020

Oct 01, 2020
SELL
$73.18 - $82.95 $104,354 - $118,286
-1,426 Reduced 0.56%
253,315 $21 Million
Q2 2020

Jul 15, 2020
SELL
$70.42 - $80.13 $45,773 - $52,084
-650 Reduced 0.25%
254,741 $19.7 Million
Q1 2020

Apr 01, 2020
SELL
$63.36 - $87.82 $17,487 - $24,238
-276 Reduced 0.11%
255,391 $19.7 Million
Q4 2019

Jan 08, 2020
SELL
$77.58 - $87.54 $86,501 - $97,607
-1,115 Reduced 0.43%
255,667 $23.3 Million
Q3 2019

Oct 02, 2019
SELL
$76.08 - $82.93 $420,342 - $458,188
-5,525 Reduced 2.11%
256,782 $21.6 Million
Q2 2019

Jul 01, 2019
SELL
$69.84 - $81.59 $320,775 - $374,742
-4,593 Reduced 1.72%
262,307 $22 Million
Q1 2019

Apr 08, 2019
SELL
$69.58 - $79.36 $330,157 - $376,563
-4,745 Reduced 1.75%
266,900 $22.2 Million
Q4 2018

Jan 03, 2019
SELL
$65.24 - $75.71 $211,051 - $244,921
-3,235 Reduced 1.18%
271,645 $20.8 Million
Q3 2018

Oct 09, 2018
SELL
$57.69 - $67.84 $265,950 - $312,742
-4,610 Reduced 1.65%
274,880 $19.5 Million
Q2 2018

Jul 03, 2018
BUY
$50.83 - $59.72 $66,993 - $78,710
1,318 Added 0.47%
279,490 $17 Million
Q1 2018

Apr 12, 2018
SELL
$50.96 - $59.23 $173,314 - $201,441
-3,401 Reduced 1.21%
278,172 $15.2 Million
Q4 2017

Jan 03, 2018
SELL
$51.62 - $61.64 $276,167 - $329,774
-5,350 Reduced 1.86%
281,573 $15.8 Million
Q3 2017

Oct 03, 2017
BUY
$58.67 - $63.13 $16.8 Million - $18.1 Million
286,923
286,923 $18.4 Million

Others Institutions Holding MRK

# of Institutions
3,830
Shares Held
1.91B
Call Options Held
13.4M
Put Options Held
10.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email